Engineered plasma cells show long-lasting antileukaemic activity in mice

Researchers show for the first time that engineered human plasma B cells can be used to treat a disease—specifically leukaemia a humanised animal model. The results mark a key step in the realization of ePCs as therapies to treat cancer, auto-immune disorders, and protein deficiency disorders. The results appear July 2 in the journal Molecular Therapy. [...]

FDA approves first gene therapy for rare pediatric immune disorder

news.medical.net - 27/Mar 19:29

Dr. Donald Kohn has been developing gene therapies for rare pediatric immune disorders for over 30 years.

Engineered bacteria deliver cancer drug directly inside tumours in mice

oncologynews.com.au - 29/Mar 17:31

Every year, millions of people are diagnosed with cancer globally; however, current treatments are limited by disease complexity. A study published...

RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease

zacks.com - 30/Mar 16:16

Rocket Pharmaceuticals drops despite the FDA's accelerated approval of gene therapy Kresladi in severe leukocyte adhesion deficiency-I, an ultra-rare...

In Vivo Gene Editing: A New Frontier in Cancer Immunotherapy

medindia.net - 27/Mar 06:04

bCancer-fighting immune cells may soon be engineered directly inside the body, removing the need for complex lab-based manufacturing./b Researchers

Researchers uncover a chain of molecular events behind early brain changes in Alzheimer's

news.medical.net - 03/Apr 17:38

For the millions of people who carry the gene APOE4, the strongest known genetic risk factor for Alzheimer's disease, their brain activity may begin...